Sec. 2709. Non-Budget Neutral Transitional Pass-Through Payment Change for Certain Products
154 words·~1 min read·
/bill/115/hr/1892/eah/section-2709·A research copy — for the controlling text, always check the official state or federal source. Not legal advice.
Subsection 1833(t)(6)(A)(iv) of the Social Security Act ( 42 U.S.C. 1395l(t)(6)(A)(iv) ) is amended by inserting (except, beginning as of April 1, 2018, a biosimilar biological product (as defined under section 1847A(c)(6)(H))) after biological . The amendment made by subsection
(a)shall apply with respect to biosimilar biological products beginning on April 1, 2018, regardless of whether such products were receiving pass-through status for an additional payment under section 1833(t)(6) of the Social Security Act ( 42 U.S.C. 1395l(t)(6) ) before such date. In the case of a product that was receiving such an additional payment pursuant to clause
(iv)of subparagraph
(A)of such section as of the day before such date and after application of the amendment under subsection
(a)is not eligible for such an additional payment as of such date, such product may not be eligible for such an additional payment pursuant to any other clause of such subparagraph (A).
Connectionstraces to 1
Traces to 1 document
U.S. Code
Citation graph
cites case law
Sec. 2709
Non-Budget Neutral Transitional Pass-Through Payment Change for Certain Products
Cites 1Cited by 0 across 0 sources